Signaturefd, LLC Arrowhead Pharmaceuticals, Inc. Transaction History

Signaturefd, LLC

$4.72 Billion
Q1 2024

A detailed history of Signaturefd, LLC transactions in Arrowhead Pharmaceuticals, Inc. stock. As of the latest transaction made, Signaturefd, LLC holds 209 shares of ARWR stock, worth $5,239. This represents 0.0% of its overall portfolio holdings.

Number of Shares

209

Previous 130 60.77%

Holding current value

$5,239

Previous $3,000 66.67%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 03, 2024	BUY	$27.21 - $39.48 $2,149 - $3,118	79 Added 60.77%	209 $5,000
Q4 2023 Jan 31, 2024	BUY	$21.2 - $31.03 $445 - $651	21 Added 19.27%	130 $3,000
Q3 2023 Nov 03, 2023	BUY	$26.2 - $36.08 $2,305 - $3,175	88 Added 419.05%	109 $2,000
Q2 2023 Aug 01, 2023	SELL	$25.16 - $41.38 $603 - $993	-24 Reduced 53.33%	21 $0
Q1 2023 Apr 28, 2023	SELL	$23.68 - $38.51 $6,227 - $10,128	-263 Reduced 85.39%	45 $1,000

Q4 2022 Jan 27, 2023	SELL	$28.0 - $40.56 $4,032 - $5,840	-144 Reduced 31.86%	308 $12,000
Q3 2022 Nov 08, 2022	BUY	$29.63 - $48.31 $6,044 - $9,855	204 Added 82.26%	452 $15,000
Q2 2022 Aug 10, 2022	BUY	$27.79 - $50.61 $6,086 - $11,083	219 Added 755.17%	248 $9,000
Q1 2022 May 02, 2022	SELL	$39.62 - $69.97 $3,843 - $6,787	-97 Reduced 76.98%	29 $1,000
Q4 2021 Jan 25, 2022	BUY	$58.09 - $82.51 $348 - $495	6 Added 5.0%	126 $8,000
Q3 2021 Oct 28, 2021	SELL	$58.38 - $84.96 $1,809 - $2,633	-31 Reduced 20.53%	120 $7,000
Q2 2021 Jul 26, 2021	SELL	$62.15 - $90.32 $1,367 - $1,987	-22 Reduced 12.72%	151 $13,000
Q1 2021 Apr 30, 2021	BUY	$61.35 - $90.47 $5,092 - $7,509	83 Added 92.22%	173 $11,000
Q4 2020 Feb 11, 2021	BUY	$43.82 - $85.37 $1,139 - $2,219	26 Added 40.63%	90 $7,000
Q3 2020 Nov 03, 2020	BUY	$33.21 - $51.27 $730 - $1,127	22 Added 52.38%	64 $3,000
Q2 2020 Jul 30, 2020	BUY	$26.12 - $43.27 $1,097 - $1,817	42 New	42 $2,000

Others Institutions Holding ARWR

# of Institutions

296

Shares Held

88.5M

Call Options Held

905K

Put Options Held

387K

View Full List

About ARROWHEAD PHARMACEUTICALS, INC.

Ticker ARWR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 105,849,000
Market Cap $2.65B
Description
Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...

More about ARWR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Signaturefd, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Signaturefd, LLC with notifications on news.

Account